COGT R&D Expenses
Cogent Biosciences Inc · R&D Expenses
COGT R&D Expenses
Latest reported$70.81Mperiod ending
COGT Quarterly R&D Expenses ($0.00 → $70.81M)
Quarterly R&D Expenses
High-resolution chart · PNG
COGT r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 70,811,000 | |
| 75,365,000 | |
| 74,382,000 | |
| 68,989,000 | |
| 61,046,000 | |
| 63,029,000 | |
| 62,045,000 | |
| 63,614,000 | |
| 54,294,000 | |
| 52,705,000 | |
| 48,719,000 | |
| 50,127,000 | |
| 38,871,000 | |
| 36,038,000 | |
| 36,742,000 | |
| 29,936,000 | |
| 29,479,000 | |
| 25,470,000 | |
| 20,514,000 | |
| 14,798,000 | |
| 12,388,000 | |
| 8,213,000 | |
| 6,108,000 | |
| 51,913,000 | |
| 5,129,000 | |
| 9,498,000 | |
| 10,354,000 | |
| 10,335,000 | |
| 10,617,000 | |
| 12,403,000 | |
| 10,765,000 | |
| 10,252,000 | |
| 9,126,000 | |
| 8,142,000 | |
| 7,562,000 | |
| 8,177,000 | |
| 7,141,000 | |
| 6,952,000 | |
| 0 | |
| 0 |